Factors Predictive of Local Disease Control after Intra-arterial Concomitant Chemoradiation (RADPLAT)

Laryngoscope

Volumn 114, Issue 3, 2004, Pages 411-417

  Robbins, K Thomas ^a,b   Doweck, Ilana ^a   Samant, Sandeep ^a   Vieira, Francisco ^a   Kumar, Parvesh ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Concomitant chemoradiation; Head and neck cancer; Local disease control; RADPLAT; Risk factors

Indexed keywords

CISPLATIN; SODIUM THIOSULFATE;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RISK FACTOR; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRA-ARTERIAL; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RISK FACTORS; SURVIVAL ANALYSIS; THIOSULFATES; TREATMENT OUTCOME;

EID: 1642348208     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200403000-00004     Document Type: Article

References (18)

1. Medow MA, Weed HG, Schuller DE. Simple predictors of survival in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2002;128:1282-1286.
2. Wendt TG, Bank P. Prognostic factors in squamous cell carcinoma of the head and neck. Onkologie 2002;25:208-212.
3. van den Brekel MW, Bindels EM, Balm AJ. Prognostic factors in head and neck cancer. Eur J Cancer 2002;38:1041-1043.
4. Baatenburg de Jong RJ, Hermans J, Molenaar J, et al. Prediction of survival in patients with head and neck cancer. Head Neck 2001;23:718-724.
5. Robbins KT, Kumar P, Wong FSH, et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck 2000;22:687-693.
6. Robbins KT, Fontanesi J, Wong FSH, et al. A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx. Arch Otolaryngol Head Neck Surg 1996;122:853-857.
7. Robbins KT, Vicario D, Seagren S, et al. A targeted supradose cisplatin chemoradiation protocol for advanced head neck cancer. Am J Surg 1994;168:419-422.
8. Robbins KT, Samant S, Vieira F, Kumar P. Cytoreduction of oral cancer using intra-arterial chemoradiation followed by limited resection: mature results of a phase II trial. Arch Otolaryngol Head Neck Surg. Submitted for publication.
9. Cooper JS, Farnan NC, Asbell SO, et al. Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer. Cancer 1996;77:1905-1911.
10. Doweck I, Denys D, Robbins KT. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy. Laryngoscope 2002;112:1742-1749.
11. Gilbert RW, Birt D, Shulman H, et al. Correlation of tumor volume with local control in laryngeal carcinoma treated with radiotherapy. Ann Otol Rhinol Laryngol 1987;96:514-518.
12. Lo SM, Venkatesan V, Matthews TW, Rogers J. Tumor volume: implications in t2/t3 glottic/supraglottic squamous cell carcinoma. J Otol 1998;27:247-251.
13. Hinerman RW, Mendenhall WM, Amdur RJ, et al. Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection. Head Neck 2002;24:456-467.
14. Begg AC, van der Kolk PJ, Dewit L, Bartelink H. Radiosensitization by cisplatin of RIF1 tumour cells in vitro. Int J Radiat Biol Relat Stud Phys Chem Med 1986;50:871-884.
15. Bartelink H, Kallman RF, Rapacchietta D, Hart GA. Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation. Radiother Oncol 1986;6:61-74.
16. Adelstein DJ, Adams GL, Li Y, et al. INT 0126: An intergroup phase III comparison of standard radiation therapy (RT) and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer (SCHNC) [abstract]. In Proceedings of the 5th International Conference on Head Neck Cancer 2000;161:107.
17. Al-Sarraf M, LeBlanc M, Shanker Giri PG, et al. Chemotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998;16:1310-1317.
18. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338:1798-1804.